This can be OK for some people who may respond well and not need a more potent drug, or those with less body fat to lose
Key findings from AMCs Impact of GLP-1 on Food Choices study: Seventy-eight percent of GLP-1 users are seeking smaller pack sizes for their food
They are made to be hyper-palatable and easy to overeat, leading to increased calorie intake without the feeling of fullness
[DOI] [PMC free article] [PubMed] [Google Scholar] [13].Verma S, Bhatta M, Davies M, Deanfield JE, Garvey WT, Jensen C, Kandler K, Kushner RF, Rubino DM, Kosiborod MN, Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials, EClinicalMedicine 55 (2023)
Trial participants who maintained 90g or more of protein daily preserved lean mass remarkably well, losing primarily fat
A.FallonM